Coherus Biosciences | CHRS - 流動資産





流動資産 変化する 日付
AbbVie USD 37.48B 3.81B 2026-09
Acadia Pharmaceuticals USD 1.27B 43.88M 2026-09
Akebia Therapeutics USD 220.78M 8.77M 2026-09
ALKERMES USD 1.58B 57.83M 2026-09
Alnylam Pharmaceuticals USD 5.11B 492.49M 2026-09
Amarin USD 612.88M 10.12M 2026-09
Amgen USD 34.36B 598M 2026-09
Baxter International USD 6.83B 163M 2026-09
Biogen USD 7.58B 278.7M 2026-09
BioMarin Pharmaceutical USD 3.92B 50.99M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Coherus Biosciences USD 133.79M 72.25M 2026-06
Eli Lilly USD 65.26B 591M 2026-09
Fujifilm JPY 1.7T 23.16B 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
Ironwood Pharmaceuticals USD 225.99M 26.79M 2026-09
Merck USD 38.94B 2.26B 2026-09
Myriad Genetics USD 289M 23.8M 2026-06
Pacira USD 10.3B 9.68B 2026-09
Perrigo USD 2.4B 49.7M 2026-09
Pfizer USD 45.01B 3.65B 2026-09
PTC Therapeutics USD 2.54B 79.58M 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Sarepta Therapeutics USD 2.27B 49.06M 2026-09
Teva Pharmaceutical Industries USD 14.6B 842M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Xencor USD 498.66M 24.55M 2026-09
Zoetis USD 6.29B 63M 2026-09